Childrens Robitussin Cough Long-acting Liquid
NDC Package 0031-8694-12
Package Information
Childrens Robitussin Cough Long-acting (dextromethorphan hydrobromide) liquids is 1.measure only with dosing cup provided2.keep dosing cup with product3.ml = milliliter4.do not take more than 4 doses in any 24-hour periodagedosechildren under 4 yearsdo not usechildren 4 to under 6 years5 ml every 6 - 8 hourschildren 6 tounder 12 years10 mlevery 6 to 8 hoursadults and children12 years and older20 mlevery 6 to 8 hours. This formulation utilizes a liquid delivery system. Marketed by Haleon Us Holdings Llc, this product is identified by NDC 0031-8694 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1370211 - dextromethorphan HBr 7.5 MG in 5 mL Oral Solution
- RxCUI: 1370211 - dextromethorphan hydrobromide 1.5 MG/ML Oral Solution
- RxCUI: 1370211 - dextromethorphan hydrobromide 15 MG per 10 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0031 - Haleon Us Holdings Llc
- 0031-8694 - Childrens Robitussin Cough Long-acting
- 0031-8694-12 - 1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE
- 0031-8694 - Childrens Robitussin Cough Long-acting
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0031-8694-12 identifies a specific commercial package of 1 bottle in 1 carton / 118 ml in 1 bottle of Childrens Robitussin Cough Long-acting, a human over the counter drug labeled by Haleon Us Holdings Llc. This liquid is formulated for oral use and contains dextromethorphan hydrobromide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Haleon Us Holdings Llc on January 01, 2004. The current certification is valid through December 31, 2026.
How is this Haleon Us Holdings Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00031869412. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.